Phaseline

Companies › Shanghai Yao Yuan Biotechnology Ltd. (also known as Drug Farm)

Shanghai Yao Yuan Biotechnology Ltd. (also known as Drug Farm): clinical trials, targets and expected readouts

1 active drug program in 2 registered trials: 2 Phase 1; Ophthalmology, Other; next expected readout Nov 2026.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
DF-003
ALPK1 inhibitor
ALPK1Phase 1Healthy; ROSAHNov 2026

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT05997641DF-003Phase 1HealthyOtherOct 2026
NCT06395285DF-003Phase 1ROSAHOphthalmologyNov 2026

Targets

ALPK1 (1)

Companies with the same targets

Pyrotech Therapeutics

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.